Monday 9 September 2013

FDA CardioBeat: Upcoming Advisory Committee Meeting

FDA CardioBeat

 

Information about FDA cardiovascular-related product approvals, safety warnings, notices of upcoming public meetings, and notices about proposed regulatory guidances. Please do not reply to this message.

Circulatory System Devices Panel of the Medical Devices Advisory Committee Meeting (Oct 8-9)

The committee will discuss, make recommendations, and vote on devices indicated for use in patients with heart failure (HF).  On October 8, 2013, the committee will discuss, make recommendations, and vote on information related to the premarket approval application regarding the expansion of indications supported by the BLOCK HF trial to apply to all market-approved Medtronic Cardiac Resynchronization Therapy-Pacemaker (CRT-P) and Cardiac Resynchronization Therapy-Defibrillator (CRT-D) devices. 

On October 9, 2013, the committee will discuss, make recommendations, and vote on information related to the premarket approval application for CardioMEMS, Inc. Champion™ HF Monitoring System.  The CardioMEMS HF System is a permanently implantable pressure measurement system designed to provide daily pulmonary arterial pressure measurements including systolic, diastolic, and mean pulmonary arterial (PA) pressure. 

For more information on the meeting, visit
http://www.fda.gov/AdvisoryCommittees/Calendar/ucm367579.htm.

 


 



This email was sent to buzzhairs.health@blogger.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

No comments:

Post a Comment